Anavex Life Sciences Market Cap

Anavex Life Sciences has a market cap or net worth of 687.97 million as of January 23, 2025. Its market cap has increased by 77.63% in one year.

Market Cap

687.97M

Enterprise Value

580.64M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

9.87

Market Cap Chart

Since April 13, 2006, Anavex Life Sciences's market cap has increased from 182.56K to 687.97M, an increase of 376,750.51%. That is a compound annual growth rate of 54.99%.

Market Cap History

Date	Market Cap	% Change
Jan 22, 2025	687.97M	-5.45%
Dec 31, 2024	727.61M	21.27%
Dec 29, 2023	599.98M	0.14%
Dec 30, 2022	599.16M	-38.45%
Dec 31, 2021	973.48M	267.56%
Dec 31, 2020	264.85M	141.31%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	171.18B
GSK plc	55.31B
Haleon	33.62B
Smith & Nephew	8.96B
ConvaTec Group	4.93B
Hikma Pharmaceuticals	4.72B
HUTCHMED (China)	1.99B
Oxford Nanopore Technologies	1.44B

Market Cap Rankings